MLTX
Price
$10.14
Change
-$0.52 (-4.88%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
643.9M
34 days until earnings call
Intraday Buy/Sell Signals
NRIX
Price
$9.18
Change
-$0.54 (-5.56%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
705.41M
126 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MLTX vs NRIX

Header iconMLTX vs NRIX Comparison
Open Charts MLTX vs NRIXBanner chart's image
MoonLake Immunotherapeutics
Price$10.14
Change-$0.52 (-4.88%)
Volume$77.1K
Capitalization643.9M
Nurix Therapeutics
Price$9.18
Change-$0.54 (-5.56%)
Volume$22.45K
Capitalization705.41M
MLTX vs NRIX Comparison Chart in %
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. NRIX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (MLTX: $10.66 vs. NRIX: $9.72)
Brand notoriety: MLTX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 91% vs. NRIX: 155%
Market capitalization -- MLTX: $676.92M vs. NRIX: $747.31M
MLTX [@Biotechnology] is valued at $676.92M. NRIX’s [@Biotechnology] market capitalization is $747.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than NRIX.

Price Growth

MLTX (@Biotechnology) experienced а +23.09% price change this week, while NRIX (@Biotechnology) price change was -2.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.86%. For the same industry, the average monthly price growth was +14.21%, and the average quarterly price growth was +268.76%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($705M) has a higher market cap than MLTX($644M). NRIX YTD gains are higher at: -51.300 vs. MLTX (-81.274). MLTX has higher annual earnings (EBITDA): -196.98M vs. NRIX (-248.7M). NRIX (429M) and MLTX (425M) have equal amount of cash in the bank . NRIX has less debt than MLTX: NRIX (56.5M) vs MLTX (75.8M). NRIX has higher revenues than MLTX: NRIX (83.7M) vs MLTX (0).
MLTXNRIXMLTX / NRIX
Capitalization644M705M91%
EBITDA-196.98M-248.7M79%
Gain YTD-81.274-51.300158%
P/E RatioN/AN/A-
Revenue083.7M-
Total Cash425M429M99%
Total Debt75.8M56.5M134%
TECHNICAL ANALYSIS
Technical Analysis
MLTXNRIX
RSI
ODDS (%)
Bullish Trend 7 days ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
68%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
58%
Bullish Trend 7 days ago
80%
MACD
ODDS (%)
Bearish Trend 7 days ago
61%
Bullish Trend 7 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
58%
Bullish Trend 7 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 28 days ago
72%
Bearish Trend 22 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
86%
Bearish Trend 7 days ago
88%
Aroon
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PURYX61.19N/A
N/A
Putnam U.S. Research Y
TIIRX28.78N/A
N/A
Nuveen Core Equity A
BRXIX16.76N/A
N/A
MFS Blended Research Intl Eq I
RESGX16.70N/A
N/A
Glenmede Environmental Accountability
WIIGX23.58N/A
N/A
Wasatch International Growth Instl

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-4.88%
KALA - MLTX
89%
Closely correlated
+1.01%
IOBT - MLTX
78%
Closely correlated
+10.56%
XNCR - MLTX
50%
Loosely correlated
-11.03%
NUVL - MLTX
49%
Loosely correlated
-5.66%
NRIX - MLTX
45%
Loosely correlated
-5.61%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-5.61%
KYMR - NRIX
66%
Closely correlated
-2.84%
DNLI - NRIX
58%
Loosely correlated
+1.34%
IDYA - NRIX
58%
Loosely correlated
+0.97%
NUVL - NRIX
55%
Loosely correlated
-5.66%
SYRE - NRIX
55%
Loosely correlated
+10.86%
More